An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.
- Submitting institution
-
University of Cambridge
- Unit of assessment
- 8 - Chemistry
- Output identifier
- 1665
- Type
- D - Journal article
- DOI
-
10.1126/sciadv.1501244
- Title of journal
- Sci Adv
- Article number
- ARTN e1501244
- First page
- e1501244
- Volume
- 2
- Issue
- 2
- ISSN
- 2375-2548
- Open access status
- Out of scope for open access requirements
- Month of publication
- February
- Year of publication
- 2016
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
13
- Research group(s)
-
-
- Citation count
- 99
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
